1,252
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Protein kinase D enzymes: novel kinase targets in pancreatic cancer

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yifan Wang, Jun Yi & Xiaowei Liu. (2022) Roles of Dclk1 in the pathogenesis, diagnosis, prognosis and treatment of pancreatic cancer: A review. Expert Review of Gastroenterology & Hepatology 16:1, pages 13-19.
Read now

Articles from other publishers (3)

Yue Du, Die Lv, Bomiao Cui, Xiaoying Li, Hongli Chen, Yingzhu Kang, Qianming Chen, Yun Feng, Ping Zhang, Jiao Chen & Xuedong Zhou. (2021) Protein kinase D1 induced epithelial–mesenchymal transition and invasion in salivary adenoid cystic carcinoma via E‐cadherin/Snail regulation. Oral Diseases 28:6, pages 1539-1554.
Crossref
Qingdi Quentin Li, Iawen Hsu, Thomas Sanford, Reema Railkar, Navin Balaji, Carole Sourbier, Cathy Vocke, K. C. Balaji & Piyush K. Agarwal. (2017) Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M. Cellular and Molecular Life Sciences 75:5, pages 939-963.
Crossref
Clara Aicart-Ramos, Sophia Dan Qing He, Marianne Land & Charles S. Rubin. (2016) A Novel Conserved Domain Mediates Dimerization of Protein Kinase D (PKD) Isoforms. Journal of Biological Chemistry 291:45, pages 23516-23531.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.